Bronchial airway tissue

Bronchial airway tissue refers to the complex anatomical structure of the bronchi, which serve as the primary conduits for air entering and leaving the lungs. This tissue is composed of various cell types, including ciliated epithelial cells, goblet cells, and smooth muscle cells, which collectively facilitate air conduction, mucociliary clearance, and immune surveillance (StatPearls, 2023). In pathological states such as asthma and chronic obstructive pulmonary disease (COPD), the bronchial airway tissue undergoes significant remodeling, chronic inflammation, and hyperresponsiveness (PubMed, 2021). While not a single molecular target, it is the primary site of action for numerous therapeutic interventions, including bronchodilators and corticosteroids, which aim to restore normal airflow and reduce airway inflammation (NIH, 2022). These drugs interact with specific receptors within the tissue, such as beta-2 adrenergic and muscarinic receptors, to modulate physiological responses (NCBI, 2023). Understanding the cellular and molecular composition of this tissue is critical for developing localized pulmonary therapies and improving patient outcomes in respiratory medicine.

Other names

Bronchial epitheliumAirway tissueBronchial mucosaBronchial wallConducting airways

Drugs acting on bronchial airway tissue typically target specific molecular components within the tissue, such as beta-2 adrenergic receptors to induce smooth muscle relaxation (bronchodilation) or glucocorticoid receptors to suppress inflammatory gene expression in epithelial and immune cells (StatPearls, 2023; PubMed, 2021).